semaglutide palpitations A SHOCKING CASE OF SEMAGLUTIDE-INDUCED VENTRICULAR ARRHYTHMIA Semaglutide use in patients undergoing
Description
The growing prevalence of metabolic disease, CKD, and ASCVD have prompted investigation into the role of GLP-1R agonists in mitigating cardiovascular and metabolic risks, particularly within the framework of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, irrespective of diabetic status
2023 May 23;14:1181913
Includes a 7-day meal plan and science-backed tips.
It helps maintain gut health, support metabolic performance, and promote immune and internal balance over time.
She presented with severe abdominal pain, vomiting, abdominal distension, and syncope
